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Differences in Peripheral Noradrenergic Function among
Actively Drinking and Abstinent Alcohol‐dependent
Individuals
We examined whether excessive alcohol consumption was related to changes in plasma levels of
noradrenaline (NA) and whether these changes recover following abstinence. We also explored
whether there were differences in NA levels between Type I and Type II alcoholics and controls
during active drinking and abstinence. Plasma concentrations of NA were determined in (1) 27
Caucasian men with alcohol dependence who were regularly drinking (active drinkers) within 24
hours of hospitalization, (2) 29 Caucasian alcohol‐dependent men who were in remission
(abstinent for a minimum of three months), and (3) 28 race‐ and gender‐matched healthy
controls. NA concentrations were significantly higher in actively drinking alcohol‐dependent
subjects compared to those in remission and controls. While Type I and Type II alcoholic
individuals differed across clinical measures, NA levels were similar in the two subtypes. Both
subtypes showed an elevation in NA levels during active drinking compared to controls, but NA
levels did not differ between the two subtypes and controls during remission. The findings
indicate that chronic exposure to alcohol may lead to disturbances in NA activity that may
manifest in early abstinence. However, the changes in NA activity appears to normalize after a
longer period of abstinence. Alterations in NA activity do not seem to be specific for Type I or
Type II subtypes of alcoholism.
Several lines of evidence support the involvement of the central noradrenergic (NA) system in
mediating the behavioral effects of alcohol (ethanol). For example, animal experiments have
shown that acute alcohol exposure increases NA synthesis and release, leading to increased NA
concentrations in the brain.1-3 The sedative, intoxicating, and locomotor effects of alcohol, as
well as alcohol withdrawal, seem to be related at least in part to increased NA activity.4-6
Studies have also found that the central NA system may contribute to the rewarding effects of
ethanol via its interaction with the dopaminergic pathways.7 Further support for the role of NA
in mediating the effects of alcohol comes from genetic knock‐out experiments. Weinshenker et
al.8 showed that mice lacking NA had a markedly reduced preference for ethanol and were
hypersensitive to the sedative and hypothermic effects of ethanol.
Compared to the preclinical evidence supporting the effects of alcohol on NA function, there
have been several inconsistencies in human data that have limited the interpretation of findings.
The conflicting findings appear to be related to the pharmacokinetics of alcohol metabolism and
several clinical variables that are difficult to control among humans. For example, alcohol's
effects on NA seem to vary with dose, length of exposure, and stage of withdrawal. While a
number of studies have replicated findings of increased NA activity during early withdrawal,9,
12 data during intoxication and abstinence have been less consistent. While subsensitive alpha‐2
adrenergic receptor function has been reported in alcoholics following extended abstinence in
some studies,13 other studies could not replicate the findings.14 Similarly, measurements of
cerebrospinal fluid levels of monoamines in recently detoxified alcoholic patients15 could not
confirm previous reports of alterations in neuroendocrine responsivity of the NA system that
were observed in similar patients.16 Moreover, the effects of acute ethanol administration have

been often studied in healthy subjects17-19 that bear little resemblance to clinical populations of
alcoholic individuals.
Biological studies in alcohol dependence are further complicated by the heterogeneity of the
clinical population.20 Studies of problem drinkers and their families have yielded two broad
categories, termed Type I and Type II by Cloninger21 and Type A and Type B by Babor et al.22
The Type II alcoholism is predominantly limited to men and represented by an earlier age of
onset of alcohol problems, greater severity of problems, stronger familial and genetic influences,
and higher impulsivity and violent behavior. In contrast, the Type I subgroup is more benign
with a later onset, higher anxiety levels, slower developmental course, fewer complications, and
a better prognosis. Biological studies have found the two subtypes may differ in measures of
serotonin,23 dopamine,24 and monoamine oxidase activity.25 Very few studies of the
noradrenergic system during different stages of alcohol dependence have taken into account the
distinct subgroups of alcoholic individuals.
In an earlier study that investigated serotonergic function in alcohol dependence, we found that
Type II alcoholism was associated with increased platelet tritiated imipramine binding that
persisted during abstinence.26 In the present study, that work is extended to examine the role of
NA system in alcoholism. The primary objective was to examine the differences in peripheral
NA levels in alcohol‐dependent individuals during active drinking and abstinence. The
secondary objective was to determine if the Type I and Type II subgroups of alcoholic patients
differ from each other and from controls in measures of NA function.

METHODS
Recruitment
The sample comprised of three groups of male, Caucasian individuals:
•

1
27 alcohol‐dependent inpatients who were still drinking.

•

2
29 alcohol‐dependent subjects who were in remission (abstinent for a minimum of three
months, termed “abstinent alcoholics”).

•

3
28 healthy volunteers with no history of alcohol dependence or abuse, serving as the
control population.

Over 90% of the clinical population from which the sample was drawn was of Caucasian
background. We restricted the population to men because Type II alcoholism is predominately
male‐limited; also, significant variations of urinary NA have been reported in women.27

The actively drinking alcohol‐dependent subjects were recruited from a university‐affiliated
inpatient addiction unit in Nottingham, England. The inclusion criteria were:
•

1
DSM‐IV diagnosis of alcohol dependence.28

•

2
No interruption of alcohol intake in the previous 72 hours and no clinical evidence of
alcohol withdrawal.

•

3
Capable of giving informed consent.

Individuals with major depression, bipolar or psychotic disorders, serious medical disorders, or a
positive urine drug screen (except benzodiazepines), as well as those receiving psychotropic
medication (except benzodiazepines), were excluded from the study. Alcohol‐dependent subjects
were recruited, and blood samples were obtained within 24 hours of admission to the inpatient
unit.
Abstinent alcoholics were recruited from a residential recovery house in Nottingham. Complete
abstinence was mandated for residing in the recovery house, and attendance at Alcoholics
Anonymous (AA) was encouraged. Most of the residents were in treatment at the outpatient
clinic or day hospital affiliated with the addiction unit and underwent random breath tests.
Subjects who were previously dependent on alcohol (DSM‐IV) but currently abstinent for at least
three months were included in the study. The exclusion criteria were similar to those for the
actively drinking group.
Controls were hospital employees or their relatives. They were excluded if they had a positive
response to items on the CAGE questionnaire, had a positive breathalyzer reading, reported
greater than 21 units of alcohol consumption per week in the previous month (one unit is
equivalent to 10 ml or 8 g of pure alcohol and corresponds to 4 fluid ounces of table wine, 1.5
fluid ounces of spirits, or 8 fluid ounces of beer), had a major psychiatric or medical disorder, or
were receiving psychotropic medication.

Behavioral and Clinical Assessments
The study protocol was approved by the ethics committee of the hospital. After a description of
the study, written informed consent was obtained. Alcohol‐dependent individuals who
volunteered for the study underwent a psychiatric interview and had their medical health
assessed by medical history and physical examination. Alcohol history was recorded in a
standardized format. Eligible subjects were asked to provide a urine sample and tested for breath
alcohol levels. Subjects then completed a battery of psychological assessments that included the
severity of alcohol dependence questionnaire (SADQ),29 a visual analogue scale for craving

(VAS),30 and a questionnaire to classify subjects into Type I and Type II subtypes of
alcoholism.21
The SADQ is a 20‐item, self‐report questionnaire that assesses severity of alcohol dependence
and requires about 20 minutes to complete. The items assess five functional areas: physical
problems, emotional problems, pattern of drinking, amount of drinking, and withdrawal
symptoms. For each item, the scores range from 0 (mild) to 3 (severe), so the total score can
range from 0–60. The reliability and validity of the instrument have been established in studies
of alcoholic patients from United Kingdom.29
The VAS has been frequently used to quantify craving for drugs and alcohol and has been used
as a subjective measure of alcohol craving.30 It can be completed in two minutes. Subjects were
asked to rate their craving on a 100 mm horizontal line, and the distance from the left end of the
line was measured in mm to provide an estimate of craving. The scores ranged from 0 (no
craving) to 100.
The Type I/Type II classification was based on procedures outlined by Gilligan et al.31 and
Sullivan et al.32 The questionnaire included 12 variables that were categorized as representing a
Type I characteristic (eg, first dependence or abuse symptom after age 25) or a Type II
characteristic (eg, family history of alcoholism). All positive responses to Type I items (ie, yes)
were weighted positively (+) and all positive responses to Type II items were weighted
negatively (—). A total score was obtained for each subject by summing scores for all items.
Subjects with scores in the positive range were classified as Type I; individuals with negative
scores received a Type II classification. A score of 0 was considered to represent “unclassified”
grouping. The questionnaire required 10–15 minutes to complete.
Consenting controls were screened using the CAGE questionnaire,33 a clinical interview, a
physical examination, and breath alcohol readings. The CAGE is a four‐item questionnaire that
takes about a minute to complete. It has been extensively employed as a screening tool to detect
alcoholism in clinical settings. A positive response to one or more of the four questions has been
found to be highly correlated with a diagnosis of alcoholism with a sensitivity of 84% and
specificity of 90%.34

The NA Assay
Twenty ml of venous blood was collected from subjects and controls. For hospitalized, alcoholic
subjects, blood was drawn within 24 hours of admission. The average time period from the time
of admission to the time of blood collection was 7.4 hours. Blood samples were collected in the
morning and transported to the laboratory on ice within two hours of blood draw to reduce the
possibility of platelet aggregation. The samples were centrifuged within four hours of arrival at
the laboratory to separate the plasma from the blood constituents. The plasma was separated and
stored at — 80 C. In the laboratory, all samples were identified by code numbers and assayed as
a single experiment to minimize variations in the plasma NA levels. The NA assay was
performed using High Performance Liquid Chromatography (HPLC) with electrochemical
detection optimized for the detection of NA. Details of the techniques for the NA assay have
been previously described.35-37 The protein assay was performed by the methods described by

Lowry et al.38 The NA concentrations were expressed in picomoles/mg of protein. The
laboratory personnel were kept blind to the clinical data.
Blood samples from alcoholic subjects were also analyzed for serum Gamma Glutamyl
Transpeptidase (GGT) and Mean Corpuscular Volume (MCV) values. Both elevated GGT and
MCV are indicative of excessive alcohol consumption and reported to be elevated in 50–75% of
alcoholic individuals.39

Statistical Analysis
Analysis of variance (ANOVA) or independent t‐tests (two‐tailed) were employed to compare
the three study groups and the Type I and Type II subgroups with respect to NA levels and
scores on the clinical variables. Chi‐square tests were used to compare dichotomous variables.
Relationships between clinical variables and NA levels were examined using Pearson or point
biserial correlations. When significant relationships were observed between NA levels and
clinical measures, the data were reanalyzed using analyses of covariance (ANCOVA) to control
for the effects of other dependent variables on NA.

RESULTS
Subjects
A total of 84 Caucasian men were studied: 27 were actively drinking, alcohol‐dependent
patients, 29 were alcohol‐dependent individuals in remission (abstinent alcoholics), and 28 were
healthy volunteers. Table 1 summarizes the demographic and clinical characteristics of the
sample.
Table 1. Clinical Characteristics of Subjects and Controls
Actively drinking (n Abstinent (n = Controls (n =
Characteristics
F/t/χ2
= 27)
29)
28)
Age (years)
39.4 ± 10.1
41.1 ± 9.4
36.6 ± 6.4
F = 1.69
χ2 =
Employed
27.5%
32.1%
93.1%
14.22†
χ2 =
Single
68.9%
75.0%
44.8%
8.26*
Duration of problem drinking
19.2 ± 10.4
20.4 ± 12.7
N/A
t = 1.18
(years)
Severity of drinking (SADQ
41.4 ± 10.6
46.5 ± 9.9
N/A
t = 1.32
scores)
Craving (VAS scores)
54.2 ± 32.1
29.6 ± 19.7
N/A
t = 2.50*
MCV‡
96 ± 6
91 ± 9
N/A
t = 1.38
GGT §
249 ± 507
48 ± 42
N/A
t = 3.61†
Benzodiazepines ¶
35.7%
28.3%
N/A
χ2 = 1.18

Characteristics
Tobacco smokers
•
•
•
•
•

Actively drinking (n Abstinent (n = Controls (n =
= 27)
29)
28)
89.6%

92.8%

34.4%

F/t/χ2
χ2 =
11.31†

* p < .05, for t tests df = 54, for χ2 df = 1–2.
† p < .01, for t tests df = 54, for χ2 df = 1–2.
‡ Normal MCV values ranged from 76–97 fl.
§ Normal GGT values ranged from 10–50 IU/L.
¶ Prescribed or present in the urine.

As seen in Table 1, the three groups did not differ significantly in age; however, alcohol‐
dependent individuals were significantly more likely to be single, unemployed, and tobacco
smokers than controls. While the actively drinking and abstinent patients did not differ in
severity or duration of drinking, the former had higher craving scores and GGT levels than the
latter group. Among patients who were actively drinking, the breath alcohol level was 121 ± 84
mg, and two patients had alcoholic hepatitis. No individuals had tested positive for HIV;
however, thirteen (23.2%) alcoholic individuals had a history of medical diseases such as liver
disease, asthma, hypertension, or diabetes, or were taking medications for their medical
conditions. Five actively drinking subjects were taking benzodiazepines (BZ); however, ten
(35.7%) had evidence of recent use of BZ in urine. More than a quarter of abstinent individuals
were prescribed BZ, and three were taking disulfiram. None of the alcoholics was prescribed
more than 20 mg of diazepam (or its equivalents) a day.

Plasma NA Levels in Alcoholic Individuals, Abstinent Alcoholics, and Controls
For technical reasons, four blood samples could not be analyzed. The NA data are reported for
eighty individuals. The plasma NA levels significantly differed between actively drinking
individuals (5.08 ± 2.32), abstinent patients (3.15 ± 1.94), and controls (3.03 ± 1.31) (F [2, 78] =
10.12, p < .001). Data analysis showed that NA levels were significantly higher in actively
drinking compared to abstinent persons and controls; the latter two groups had similar NA
concentrations. Figure 1 shows the distribution of plasma NA concentrations in the three groups.

Figure 1
Open in figure viewerPowerPoint
Plasma noradrenaline in active drinkers, controls, and abstinent alcoholics.
Since there were demographic differences between the three groups, we examined whether these
variables were related to plasma NA levels. We found that NA levels were not significantly
correlated with employment, marital status, or smoking status (X2 ranged from 0.48 to 1.87, df =
2, p > .05 in each case), or with GGT values, breath alcohol levels, craving scores (r ranged from
.05 to .17, p > .05 in each case). We also compared NA levels between alcoholic individuals
taking benzodiazepines and those who were not, and found no significant differences between
the two groups (X2 = 2.11, df = 1, p > .05). We then assessed the influence of comorbid medical
diseases (eg, hypertension, asthma) on NA levels in alcoholic individuals by comparing the NA
levels between patients with concurrent medical disorders (n = 13) and those without such
disorders (n = 43). No significant difference was found between the two groups = 1.87, df = 1, p
> .05).
We also examined the relationship between clinical variables (severity and duration of drinking,
craving, and duration of abstinence) and plasma NA levels in alcoholic patients. A significant
positive correlation was observed between NA levels and the total score (r = 0.38, p < .05) and
scores on the quantity (r = 0.37, p < .05) and withdrawal sub‐scales (r = .35, p < .05) of the
SADQ. However, duration of drinking or craving scores were not significantly correlated with
NA concentrations. Among abstinent alcoholics, the duration of abstinence was 5.9 ± 3.3
months. Two patients were abstinent more than twelve months, with the maximum duration
being sixteen months. No significant correlation was observed between duration of abstinence
and NA concentrations (r = .18, p > .05).

NA Levels in Type I and Type II Alcoholics
In the combined alcoholic sample, 23 individuals were classified as Type I, 28 as Type II, and
five were rated as “unclassified”. While the two subtypes did not differ in demographics, Type II
alcoholics were more likely to have a longer duration of drinking (t = 2.58, df = 49, p < .05),
higher GGT values (t = 2.38, df = 49, p < .05), and higher scores on the physical problems
subscale of the SADQ (t = 2.17, df = 47, p< .05). The other clinical variables did not differ
between the two subtypes. Because the alcohol‐dependent group who were drinking regularly
had higher NA levels than controls, we examined whether Type I (n = 12) and Type II (n = 13)
individuals in this group differed in their NA levels. No significant differences in NA levels were
observed between Type I (4.96 ± 1.98) and Type II (4.98 ± 2.73) individuals (t = .21, df = 23, p
> .05). Since Type I and Type II individuals differed in certain SADQ measures and SADQ
scores were related to NA levels, we reanalyzed the data covarying for SADQ scores. The
ANCOVA analysis did not change the direction or significance of the findings.

DISCUSSION
NA Levels During Alcohol Dependence and Abstinence
The present study found that plasma NA levels were significantly elevated in chronic alcohol‐
dependent men who were still drinking compared to those who were abstinent for at least three
months and controls. Because blood samples in the alcohol‐dependent group were drawn at
different time points and breath alcohol levels were variable, it is difficult to uniformly
characterize the clinical and physiological status of this group. Although some patients clinically
had signs of intoxication and blood samples were collected before clinical signs of withdrawal
were evident, patients had stopped drinking over seven hours before the blood draw. Therefore,
it seems that physiologically most patients were in an early asymptomatic abstinent state. The
increase in NA levels observed in this state is consistent with the animal data regarding the
effects of alcohol on the noradrenergic system.1, 2 The results also support previous studies in
humans that found plasma catecholamines to be increased following alcohol exposure and
withdrawal12, 40 and reports of down‐regulation of alpha‐2 receptors in recently detoxified
alcoholic subjects.16, 41 However, contrasting findings have also been reported possibly related
to differences in stages of alcohol dependence. For example, Ibsen et al.42 have also reported
normal NA concentrations in chronic, stable alcoholics, though it was unclear in this study
whether subjects were in early withdrawal. Contrary to our expectations, breath alcohol levels
were not correlated with plasma NA levels in the actively drinking group. One reason could be
that a single breath alcohol value does not indicate whether blood alcohol levels were stable,
increasing, or declining in a particular individual. It is likely that a proportion of patients might
have reduced their consumption before hospitalization and, although intoxicated, may actually
have had declining blood alcohol levels. Another reason for the lack of correlation between NA
and alcohol levels could be individual differences in the magnitude of physiological tolerance
and dependence on alcohol. We also failed to find a relationship between NA levels and craving
during active drinking and abstinence, supporting findings from a recent study that did not
observe a relationship between levels of NA metabolites in cerebrospinal fluid cue‐induced
craving in alcohol‐dependent subjects.15 It seems that dopaminergic and serotonergic

mechanisms may be preferentially involved in mediating craving for drugs and alcohol along
with cognitive, affective, and psychological factors.43, 44

NA Levels in Type I and Type II Alcoholism
As expected, the Type II alcoholics had a longer duration of drinking, more physical problems,
and higher levels of GGT and also tended to drink more compared to the Type I group. After
correcting for these clinical differences, NA levels were similar in Type I and type II alcoholics
during active drinking and abstinence. While there is a large body of evidence that Type I and
Type II alcoholics may differ in serotonergic23, 45 and dopaminergic24 function the data on
differences in NA function between the two subtypes have been less robust. While early research
indicated that there may be differences in platelet mono‐amine oxidase (MAO) activity between
the two subtypes 21, 25 two genetic studies have yielded negative results.46, 47 Although there
have been suggestions that the Type I alcoholics may have higher anxiety levels than the Type II
subgroup our study did not find any differences in plasma NA between the two subtypes.
However it is possible that although NA levels may have normalized within a few weeks of
abstinence changes in adrenergic receptor function could persist for much longer periods.13
Further research comparing adrenergic receptor function between the two subtypes during
abstinence may clarify whether the two subtypes are characterized by differences in the
noradrenergic system.

Methodological Issues
Given the variations in effects of alcohol on the NA metabolism selection of sample becomes
critical in biological studies of alcoholics. Because our objective was to compare chronic
alcohol‐dependent patients who were actively drinking with those who were abstinent we studied
alcoholics before clinical withdrawal was evident and recruited subjects with elevated levels of
alcohol in the breath. This also ensured that subjects were not started on detoxification regimens
with large doses of benzodiazepines that can suppress NA activity.48 Similarly abstinence was
determined by objective data controls were clinically screened and Type I and Type II
classifications were obtained using standardized assessments. We also examined the effects of
potential confounding variables such as duration and severity of drinking and the use of tobacco
and concomitant benzodiazepines. Nevertheless the data have to be interpreted in light of certain
limitations. First the stress of hospitalization itself may have increased the levels of NA in the
actively drinking group. Because we did not measure other biochemical indices such as cortisol
levels or NA metabolites it was not possible to distinguish between the effects of alcohol and
stress of hospitalization in our subjects. However studies have shown that stress by itself cannot
explain the increases in NA seen in hospitalized alcoholics.49 Also it is likely that both
controls—who were unaccustomed to screening interviews, breath tests, and venepuncture—and
recovering alcoholics—whose behavior was heavily regulated in the residential facilities—also
experienced stress. Finally, the interaction between alcohol and stress is not necessarily
synergistic but may also be antagonistic. For example, in experimental animals, alcohol given
prior to immobilization (ie, stress) has been found to reduce the restraint‐induced elevations in
NA.50 Given these circumstances, it seems that the over 60% increase in NA in the actively
drinking alcoholics compared to the other two groups does not seem to be due to stress of
hospitalization alone. Second, the extent to which plasma NA reflects changes in NA function in

human brain is unclear. Certain metabolic differences are present between periphery and the
brain in humans that may need to be considered during interpretation of data (eg, high‐affinity
alcohol dehydrogenase enzyme is absent in the brain51). However, human studies have found
correlations between brain and plasma levels of MHPG and NA, and plasma NA and its
metabolites are believed to be a major determinant of levels of NA in the cerebrospinal fluid.52
We also acknowledge that the small sample size may have affected the ability to detect
hypothesized differences in NA levels between the Type I and Type II subtypes or the possible
differences between alcoholics with high and low amounts of drinking. Finally, since the sample
was restricted to Caucasian men to control for possible race and gender effects, the data cannot
be generalized to women and to individuals from other ethnic backgrounds.

Clinical Significance and Conclusions
The increases in NA levels in alcohol‐dependent individuals who were actively drinking indicate
that chronic exposure to alcohol may lead to disturbances in NA activity that may be manifested
in early abstinence. The normalization of NA levels with a longer period of abstinence suggests
that the alcohol‐induced NA changes may be state‐dependent phenomena. Although the Type I
and Type II alcoholics differ clinically, NA measures do not appear to distinguish between the
two subtypes. Determining the influence of selective NA agents on the central effects of alcohol
as well as examining the relationships between NA and dopaminergic mechanisms during
different stages of alcohol dependence may clarify the importance of the NA system in mediating
the addictive properties of alcohol in humans.
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